Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Globe Life Inc banner

Globe Life Inc
F:TMJ

Watchlist Manager
Globe Life Inc Logo
Globe Life Inc
F:TMJ
Watchlist
Price: 150 EUR 0.6% Market Closed
Market Cap: €14.1B
Write Note Create Alert Ask AI

Wall St Price Targets

TMJ Price Targets Summary
Globe Life Inc

Wall Street analysts forecast TMJ stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TMJ is 132.03 EUR with a low forecast of 113.62 EUR and a high forecast of 160.1 EUR.

TMJ Lowest Forecast
Wall Street Target
€113.62
-24% Downside
TMJ Average Forecast
Wall Street Target
€132.03
-12% Downside
TMJ Highest Forecast
Wall Street Target
€160.1
7% Upside
Lowest Forecast
Price Target
113.62 EUR
24% Downside
Average Forecast
Price Target
132.03 EUR
12% Downside
Highest Forecast
Price Target
160.1 EUR
7% Upside
Globe Life Inc Competitors:
Price Targets

Revenue
Forecast

4% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
4% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 4 years is 6%.

What are analyst estimates?

Net Income
Forecast

6% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
6% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 4 years is 5%.

What are analyst estimates?

Continue TMJ Research

Summary
TMJ intrinsic value, competitors valuation, and company profile.
DCF Valuation
TMJ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TMJ stock valuation using valuation multiples.
Wall St Estimates
TMJ price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TMJ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Globe Life Inc listings:
NYSE • USD
GL
 XMUN • EUR
TMJ
 DUS • EUR
TMJ
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TMJ's stock price target?
Price Target
132.03 EUR

According to Wall Street analysts, the average 1-year price target for TMJ is 132.03 EUR with a low forecast of 113.62 EUR and a high forecast of 160.1 EUR.

What is the Revenue forecast for Globe Life Inc?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 4 years is 6%.

What is the Net Income forecast for Globe Life Inc?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 4 years is 5%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.